Cargando…

Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy

Detalles Bibliográficos
Autores principales: Coelingh Bennink, Herjan J.T., Foidart, Jean-Michel, Debruyne, Frans M.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Association of Urology. Published by Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257425/
https://www.ncbi.nlm.nih.gov/pubmed/34274135
http://dx.doi.org/10.1016/j.eururo.2021.06.024
_version_ 1783718310251069440
author Coelingh Bennink, Herjan J.T.
Foidart, Jean-Michel
Debruyne, Frans M.J.
author_facet Coelingh Bennink, Herjan J.T.
Foidart, Jean-Michel
Debruyne, Frans M.J.
author_sort Coelingh Bennink, Herjan J.T.
collection PubMed
description
format Online
Article
Text
id pubmed-8257425
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Association of Urology. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-82574252021-07-06 Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy Coelingh Bennink, Herjan J.T. Foidart, Jean-Michel Debruyne, Frans M.J. Eur Urol Research Letter European Association of Urology. Published by Elsevier B.V. 2021-10 2021-07-06 /pmc/articles/PMC8257425/ /pubmed/34274135 http://dx.doi.org/10.1016/j.eururo.2021.06.024 Text en © 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Research Letter
Coelingh Bennink, Herjan J.T.
Foidart, Jean-Michel
Debruyne, Frans M.J.
Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy
title Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy
title_full Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy
title_fullStr Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy
title_full_unstemmed Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy
title_short Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy
title_sort treatment of serious covid-19 with testosterone suppression and high-dose estrogen therapy
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257425/
https://www.ncbi.nlm.nih.gov/pubmed/34274135
http://dx.doi.org/10.1016/j.eururo.2021.06.024
work_keys_str_mv AT coelinghbenninkherjanjt treatmentofseriouscovid19withtestosteronesuppressionandhighdoseestrogentherapy
AT foidartjeanmichel treatmentofseriouscovid19withtestosteronesuppressionandhighdoseestrogentherapy
AT debruynefransmj treatmentofseriouscovid19withtestosteronesuppressionandhighdoseestrogentherapy